Metabolic Consequences of Hypoxia from Birth and Dexamethasone Treatment in the Neonatal Rat: Comprehensive Hepatic Lipid and Fatty Acid Profiling
Open Access
- 1 November 2004
- journal article
- other
- Published by The Endocrine Society in Endocrinology
- Vol. 145 (11) , 5364-5372
Abstract
Neonatal hypoxia is a common condition resulting from pulmonary and/or cardiac dysfunction. Dexamethasone therapy is a common treatment for many causes of neonatal distress, including hypoxia. The present study examined the effects of dexamethasone treatment on both normoxic and hypoxic neonatal rats. We performed comprehensive hepatic fatty acid/lipid profiling and evaluated changes in pertinent plasma hormones and lipids and a functional hepatic correlate, i.e. hepatic lipase activity. Rats were exposed to hypoxia from birth to 7 d of age. A 4-d tapering dose regimen of dexamethasone was administered on: postnatal day (PD)3 (0.5 mg/kg), PD4 (0.25 mg/kg), PD5 (0.125 mg/kg), and PD6 (0.05 mg/kg). The most significant finding was that dexamethasone attenuated nearly all hypoxia-induced changes in hepatic lipid profiles. Hypoxia increased the concentration of hepatic triacylglyceride and free fatty acids and, more specifically, increased a number of fatty acid metabolites within these lipid classes. Administration of dexamethasone blocked these increases. Hypoxia alone increased the plasma concentration of cholesterol and triacylglyceride, had no effect on plasma glucose, and only tended to increase plasma insulin. Dexamethasone administration to hypoxic pups resulted in an additional increase in plasma lipid concentrations, an increase in insulin, and a decrease in plasma glucose. Hypoxia and dexamethasone treatment each decreased total hepatic lipase activity. Normoxic pups treated with dexamethasone displayed increased plasma lipids and insulin. The effects of dexamethasone on hepatic function in the hypoxic neonate are dramatic and have significant implications in the assessment and treatment of metabolic dysfunction in the newborn.Keywords
This publication has 53 references indexed in Scilit:
- Outcomes at School Age after Postnatal Dexamethasone Therapy for Lung Disease of PrematurityNew England Journal of Medicine, 2004
- For Debate: Fetal and early postnatal growth restriction lead to diabetes, the metabolic syndrome and renal failure*Diabetologia, 2003
- Hormonal regulation of lipoprotein lipase activity from 5-day-old rat hepatocytesMolecular and Cellular Endocrinology, 1996
- A dexamethasone-induced protein stimulates Δ9-desaturase activity in rat liver microsomesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1988
- Modulation of Δ6 and Δ5 rat liver microsomal desaturase activities by dexamethasone-induced factorBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1986
- Biochemistry of liver development in the perinatal periodCellular and Molecular Life Sciences, 1983
- Effect of chronic hypoxia on hepatic triacylglycerol concentration and mitochondrial fatty acid oxidizing capacity in liver and heartActa Physiologica Scandinavica, 1978
- Fatty Acid Metabolism in Hypoxic Rat LiverRespiration, 1977
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976
- Subcellular fractionation, partial purification and characterization of neutral triacylglycerol lipase from pig liverBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1975